If you want to generate a significant income stream from your portfolio, you need high-quality dividend growth stocks with above-average yields.
The Schwab U.S. Dividend Equity ETF (SCHD) offers just that package.
It has a combined 40% of the portfolio in consumer staples and healthcare stocks, but only 9% in tech.
The dream of many investors is to create a portfolio that does the work for you: to build a big enough portfolio that the long-term power of compounding does more for your wealth creation than you are.
The good news is that it's very achievable. With the proper planning, discipline, and long-term commitment, you can create a substantial passive income stream that helps get you closer to retirement or just pay the bills.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
But you need to know what it takes to get there. Without a plan, it's little more than hope. Understanding the numbers and choosing the right exchange-traded fund (ETF) is the plan that actually gets you there.
The right ETF for me is the Schwab U.S. Dividend Equity ETF (NYSEMKT: SCHD).
Image source: Getty Images.
Before we get into why the Schwab U.S. Dividend Equity ETF is the right fund for the job, let's look at the numbers.
Generating $500 per month equates to $6,000 per year. The fund's current yield is right around 3.3%. Taking the $6,000 per year income goal and dividing it by the 3.3% yield, you'd need an initial investment of just under $182,000 to make it happen. At a current price of $33.47, you'd need to buy around 5,433 shares.
That's not an insignificant amount of money. But even if you don't have that now, you can begin working toward it with an automatic monthly investment plan and regular dividend reinvestments. Very few people start with that kind of capital, but the "brick-by-brick" approach can get you there in time.
The Schwab U.S. Dividend Equity ETF is based on dividend growth, dividend quality, and high yield. It focuses on investing in companies that demonstrate strong, healthy balance sheets and a history of paying and growing their dividends.
The final portfolio of roughly 100 stocks tends to be more value-oriented and a bit boring. The top five holdings (and their portfolio weight) currently are:
In other words, this group contains none of the big tech, artificial intelligence (AI), or semiconductor names that have dominated the news cycle.
In fact, tech is only the 6th-largest sector holding in the fund, accounting for just 9% of assets. Healthcare and consumer staples each have a 20% weighting, and energy comes in third with 14%.
That's exactly why this fund works. It's not overvalued. It's heavily invested in mature, well-established companies built to withstand more challenging economic environments and continue distributing dividends to shareholders.
If you're looking to build a consistent income stream from your portfolio, whether it's $100 a month, $500 a month, or even more, the Schwab U.S. Dividend Equity ETF is the right fund to do it with.
Before you buy stock in Schwab U.S. Dividend Equity ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Schwab U.S. Dividend Equity ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $395,463!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,268,290!*
Now, it’s worth noting Stock Advisor’s total average return is 929% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of August 5, 2026.
David Dierking has positions in Schwab U.S. Dividend Equity ETF. The Motley Fool has positions in and recommends Abbott Laboratories, Amgen, and Merck. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.